Type of security: Stock
Sector: Health Care
Industry: Major Pharmaceuticals
The data is delayed by 15 minutes.
Description: Synergy Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development of drugs to treat gastrointestinal (GI) disorders and diseases. Its lead product candidate is plecanatide, a guanylyl cyclase C receptor agonist that is in Phase III clinical trials to treat chronic idiopathic constipation GI disorders, as well as is in Phase IIb clinical trials for the treatment of constipation-predominant irritable bowel syndrome GI disorders. The company also develops SP-333, which is in Phase II clinical trials to treat GI inflammatory diseases, such as ulcerative colitis. Synergy Pharmaceuticals Inc. is headquartered in New York, New York.
See how to gain 20% in 14 sec with TrendsInvesting
|Shares Outstanding||EPS||EPS Growth - 4 Quarters||EPS Growth - Q/Q|
|EPS Growth - Y/Y||Sales Growth - 4 Quarters||Sales Growth - Q/Q||P/E|
|P/E To EPS Growth||P/S||P/BV||Price/Cash Per Share|
|Price/Free Cash Flow||ROA||-54.85%||ROE||432.02%||ROI|
|Current Ratio||9.53||Quick Ratio||Long Term Debt/Equity||1.23||Debt Ratio||-0.77|
|Gross Margin||Operating Margin||Net Profit Margin||Dividend Payout Ratio|
|Cash From Financing Activities||5.41 M||Cash From Investing Activities||-50.01 M||Cash From Operating Activities||-23.15 M||Gross Profit|
|Net Profit||-27.39 M||Operating Profit||-22.8 M||Total Assets||194.83 M||Total Current Assets||182.28 M|
|Total Current Liabilities||19.13 M||Total Debt||200 M||Total Liabilities||219.57 M||Total Revenue|
|High 52 week||2.23||Low 52 week||0.07||Last close||0.24||Last change||-17.21%|
|RSI||42.37||Average true range||0.03||Beta||0.79||Volume||31.45 M|
|Simple moving average 20 days||-22.7%||Simple moving average 50 days||-1.08%||Simple moving average 200 days||-79.06%|
|Performance Week||-22.62%||Performance Month||-36.75%||Performance Quart||-37.23%||Performance Half||-87.69%|
|Performance Year||-87.09%||Performance Year-to-date||110.8%||Volatility daily||9.36%||Volatility weekly||20.93%|
|Volatility monthly||42.89%||Volatility yearly||148.57%||Relative Volume||577.63%||Average Volume||13.41 M|
|New High||New Low|
2019-03-12 16:57:33 | [$$] Synergy Pharma Bankruptcy Plan Cleared for Creditor Poll
2019-03-06 09:00:00 | Bausch Health Completes Acquisition Of Certain Assets Of Synergy Pharmaceuticals Inc.
2019-03-05 08:04:11 | See what the IHS Markit Score report has to say about Synergy Pharmaceuticals Inc.
2019-03-04 14:12:13 | Chester County to lose 137 pharma jobs
2019-02-26 18:04:00 | Bausch Health to Acquire Certain Assets of Synergy Pharmaceuticals Inc.
2019-02-25 12:35:45 | [$$] Puerto Rico's Debt Saga May Land Back in Washington's Lap
2019-02-22 17:48:17 | [$$] Synergy Pharmaceuticals Wins Approval for Bankruptcy Loan
2019-02-20 17:11:00 | Investor Alert: Kaplan Fox Announces Investigation Of Synergy Pharmaceuticals Inc.
2019-02-20 17:08:49 | Bausch Health Companies Inc BHC Q4 2018 Earnings Conference Call Transcript
2019-02-13 11:41:57 | [$$] Firm Retention Summary: Synergy Pharmaceuticals Inc.
2019-02-11 17:29:58 | SYNERGY PHARMACEUTICALS, INC. INVESTOR ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that it filed a securities class action lawsuit in the United States District Court for the Eastern District of New York against Synergy Pharmaceuticals, Inc
2019-01-29 08:04:59 | See what the IHS Markit Score report has to say about Synergy Pharmaceuticals Inc.
2019-01-25 08:00:00 | Small Cap Stocks Breaking Out
2019-01-23 12:11:07 | [$$] Firm Retention Summary: Synergy Pharmaceuticals Inc.
2019-01-17 16:51:22 | [$$] Transparency Takes Center Stage in Pharma Bankruptcy
2019-01-17 08:02:10 | See what the IHS Markit Score report has to say about Synergy Pharmaceuticals Inc.
2019-01-09 08:03:43 | See what the IHS Markit Score report has to say about Synergy Pharmaceuticals Inc.
2019-01-07 10:46:20 | [$$] Charlotte Russe Reassesses Its Future, Including Sale or Bankruptcy
2019-01-04 17:52:13 | [$$] Synergy Pharmaceuticals Wins Court Approval for Extended Sale Process
2019-01-04 10:10:00 | These 4 Healthcare Stocks Are Making Moves
2019-01-02 11:55:00 | These 4 Healthcare Stocks Are Kicking Off The New Year With A Bang
2018-12-31 08:59:00 | 4 Pharma Stocks Gaining Speed on Monday 12/31/18
2018-12-28 13:33:17 | [$$] Firm Retention Summary: Synergy Pharmaceuticals Inc.
2018-12-21 10:45:00 | These 4 Pharma Stocks Could Test December Highs
2018-12-20 08:02:09 | See what the IHS Markit Score report has to say about Synergy Pharmaceuticals Inc.
2018-12-19 12:30:00 | These 4 Pharma Stocks Are Heating Up
2018-12-18 06:40:00 | 4 Stocks to Watch Pre-Market on Tuesday 12/18/2018
2018-12-17 13:30:00 | 4 Stocks Providing Investor Opportunity Right Now
2018-12-17 10:33:22 | [$$] Neiman Marcus Asks Court to Dismiss Lawsuit by Marble Ridge
2018-12-17 07:00:00 | Cipher Pharmaceuticals Announces PLECANATIDE Accepted for Review by Health Canada
2018-12-14 13:50:14 | [$$] Synergy Pharmaceuticals Kicks Off Path Toward Sale
2018-12-13 09:02:02 | Bausch BHC Bids for Assets of Synergy Pharmaceuticals